Meningiomas, benign tumors that arise from the meninges, the membrane that envelops the brain and spinal cord, represent a significant portion of central nervous system neoplasms. Their vascular nature and relatively predictable locations within the cranial cavity make them prime candidates for preoperative embolization—a technique aimed at reducing tumor blood supply prior to surgical resection.
Health
The landscape of medical regulation is increasingly complex, as highlighted during an FDA advisory committee meeting where discussions centered around the fate of andexanet alfa, better known as Andexxa. Donald Kohn, MD, from UCLA, encapsulated the tension within regulatory frameworks by stating, “It’s a real regulatory dilemma here.” The challenges faced in approving such drugs
As President-elect Donald Trump announces his nominees for key health positions, the implications of these selections ripple through both political and public health landscapes. The nominations of former Rep. Dave Weldon as the director of the Centers for Disease Control and Prevention (CDC) and Dr. Janette Nesheiwat as the next Surgeon General reflect an administration
The recent announcement of Dr. Marty Makary as the nominee for the Food and Drug Administration (FDA) under President-elect Donald Trump has stirred significant conversation regarding the future direction of the agency. With a background in surgical oncology, health policy, and health communication, Makary brings a unique perspective that could potentially reshape the regulatory landscape
A recent survey conducted by the CDC has unveiled that chronic pain affects nearly one in four adults in the U.S., indicating a serious public health issue that can no longer be overlooked. With a staggering 24.3% of adults reporting experiences of chronic pain lasting three months or longer, as highlighted by Jacqueline Lucas and
On a recent Tuesday, an FDA advisory committee made significant strides in addressing patient care regarding the antipsychotic medication clozapine, used predominantly for treating schizophrenia and schizoaffective disorders. The committee voted overwhelmingly, with only one dissenting voice out of fifteen, to eliminate the Risk Evaluation and Mitigation Strategy (REMS) tailored to manage the risks of
In a landscape increasingly dominated by a quest for dietary solutions to cognitive decline, a recent study has thrown a wrench into the established narrative surrounding omega-3 fatty acids, particularly docosahexaenoic acid (DHA). The findings from the PreventE4 trial, presented at the Clinical Trials on Alzheimer’s Disease conference in Madrid, reveal intriguing nuances regarding DHA
The pursuit of improved public health strategies often necessitates innovative approaches. One recent study indicates that electronic nudges significantly enhance flu vaccination uptake, particularly among patients with a history of acute myocardial infarction (MI). Conducted as a series of randomized trials in Denmark, the results paint a promising picture for the integration of personalized messaging
The selection of leaders within health policy can have significant implications for the direction and effectiveness of healthcare initiatives. Recent commentary regarding president-elect Donald Trump’s decision to appoint Robert F. Kennedy Jr. to head the Department of Health and Human Services has prompted scrutiny from various experts in the field. Dr. Wendell Primus, a distinguished
The management of ventricular tachycardia (VT) in patients suffering from ischemic cardiomyopathy has long been a contentious issue in cardiology, with varying approaches in treatment strategies. The recent findings from the VANISH2 trial present compelling evidence supporting the priority of catheter ablation over the traditional initial use of antiarrhythmic medications. This article delves deep into